Pediatric Vaccines Market to be more than USD 40 Billion Globally by 2022

About This Presentation
Title:

Pediatric Vaccines Market to be more than USD 40 Billion Globally by 2022

Description:

Pediatric Vaccine is given to the children in the age which are from 0-18 years. Vaccines are given to children to fight from diseases, infections, seasonal variations and from unhygienic conditions. Vaccination varies from disease to disease; vaccines are given to children at regular intervals. The cases like of Polio, Haemophilus Influenza Type B(HIB) and MMR have shown continuously fallen down from the year 2001 to 2011. The primary reason for this is that India is on a verge of Polio free country as not a single case of Polio reported in recent years. For more Information: – PowerPoint PPT presentation

Number of Views:1

less

Transcript and Presenter's Notes

Title: Pediatric Vaccines Market to be more than USD 40 Billion Globally by 2022


1
Pediatric Vaccines Market to be more than USD 40 Billion Globally by 2022
Category Life Science
2
Pediatric Vaccines Market to be more than USD 40
Billion Globally by 2022 Analyst View Over a
period of time, Pediatric Vaccines Market has
been mounting at a great pace. Pediatric Vaccines
Market worldwide is estimated to be more than US
40 Billion by the year 2022. Press Release
Title Pediatric Vaccines Market to be more
than USD 40 Billion Globally by 2022 For More
Information http//www.renub.com/pediatric-vaccin
es-market-to-be-more-than-usd-40-billion-globally-
by-2022-33-nd.php

3
Pediatric Vaccines Market to be more than USD 40
Billion Globally by 2022
Download full Report http//www.renub.com/pediatr
ic-vaccines-market-doses-immunization-cases-and-fo
recast-worldwide-analysis-166-p.php Pediatric
Vaccines Market is more enhanced by combination
vaccines and Boosters vaccines as it is expected
to show good growth in coming years because of
the higher margins. Pediatric Vaccine is given
to the children in the age which are from 0-18
years. Vaccines are given to children to fight
from diseases, infections, seasonal variations
and from unhygienic conditions. Vaccination
varies from disease to disease vaccines are
given to children at regular intervals. The cases
like of Polio, Haemophilus Influenza Type B(HIB)
and MMR have shown continuously fallen down from
the year 2001 to 2011. The primary reason for
this is that India is on a verge of Polio free
country as not a single case of Polio reported in
recent years. 500 Million Infants to get
Immunization by 2022 Immunization is vital
component for modern day vaccine and is of
paramount importance for worldwide health.
Certain standard of immunizations program planned
in order to have desired time interval between
vaccines doses.

4
Pediatric Vaccines Market to be more than USD 40
Billion Globally by 2022
Over 500 million infants get immunization by the
year 2022 owing to increasing concern against
Vaccine preventable diseases and rising
awareness. Overall Immunization processes for
children have many vaccines in common but, it
depends upon region to region. Mostly developed
countries follow similar primary immunization
schedule, as opposed to developing countries.
Another reflection relating to International
immunization is the use of Travel Vaccines. This
is because as the number of International
travelers including children continue to rise, as
children are more at risk of microbial infection
than adults. Hepatitis, Polio and Meningococcal
are often prioritized over precise Travel
Vaccines, as these diseases are still prevailing
in many developing countries. Typhoid Fever,
Yellow Fever, Encephalitis etc are the next
concern, as these diseases are common in
developing countries irrespective of Travel
Vaccine. Some of the Pediatric Vaccine Market
players are GlaxoSmithKline, Merck Co. Inc,
Pfizer Inc, Sanofi, Panacea BioTech, Zydua
Cadila, Emergent BioSolution Inc, Serum Institute
of India Pvt Ltd, Bharat Biotech and Indian
Immunologicals Ltd.

5
Pediatric Vaccines Market to be more than USD 40
Billion Globally by 2022



6
Pediatric Vaccines Market to be more than USD 40
Billion Globally by 2022

The Report Studies the
Pediatric Vaccines Market on the basis
of Vaccines Market (2011 2022)
  • 1. Influenza
  • 2. MMR (Measles, Mumps, and Rubella)
  • 3. Pneumococcal
  • 4. Meningococcal
  • 5. Hepatitis
  • DTap (Diphtheria, Tetanus, Pertussis)
  • 7. Haemophilus influenzae type B
  • 8. Polio
  • 9. Rotavirus
  • 10. Varicella
  • 11. Combination Vaccine


Key Players (2011 2022) 1. GlaxoSmithKline, plc
2. Merck Co. 3. Sanofi Pasteurs 4.
Pfizer, Inc.s
7
Pediatric Vaccines Market to be more than USD 40
Billion Globally by 2022
Life Science News http//www.renub.com/life-scie
nce-1-n.php
  •  Renub Research - North America
  • Rajat Gupta
  • 225 Kristie Ln, Roswell
  • Georgia 30076, United States
  • Tel 1-678-302-0700
  • Email info_at_renub.com
  • www.renub.com
  •  
  • Renub Research - Asia
  • Ankit Mishra
  • C 86, Sector 10
  • Noida 201301, India
  • Tel 91-120-421-9822
Write a Comment
User Comments (0)